SIL Investments Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 11:13 pm

Competitors of SIL Investments Ltd

All Competitor Stocks of SIL Investments Ltd

Quarterly Result

Last Updated: August 20, 2025, 3:35 am

Below is a detailed analysis of the quarterly data for SIL Investments Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 12.57 Cr.. The value appears strong and on an upward trend. It has increased from 0.58 Cr. (Mar 2025) to 12.57 Cr., marking an increase of 11.99 Cr..
• For Expenses, as of Jun 2025, the value is 2.48 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.51 Cr. (Mar 2025) to 2.48 Cr., marking a decrease of 0.03 Cr..
• For Operating Profit, as of Jun 2025, the value is 10.09 Cr.. The value appears strong and on an upward trend. It has increased from -1.93 Cr. (Mar 2025) to 10.09 Cr., marking an increase of 12.02 Cr..
• For OPM %, as of Jun 2025, the value is 80.27%. The value appears strong and on an upward trend. It has increased from -332.76% (Mar 2025) to 80.27%, marking an increase of 413.03%.
• For Other Income, as of Jun 2025, the value is 1.10 Cr.. The value appears strong and on an upward trend. It has increased from 0.38 Cr. (Mar 2025) to 1.10 Cr., marking an increase of 0.72 Cr..
• For Interest, as of Jun 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.01 Cr..
• For Depreciation, as of Jun 2025, the value is 0.69 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.63 Cr. (Mar 2025) to 0.69 Cr., marking an increase of 0.06 Cr..
• For Profit before tax, as of Jun 2025, the value is 10.49 Cr.. The value appears strong and on an upward trend. It has increased from -2.19 Cr. (Mar 2025) to 10.49 Cr., marking an increase of 12.68 Cr..
• For Tax %, as of Jun 2025, the value is 21.93%. The value appears to be improving (decreasing) as expected. It has decreased from 31.51% (Mar 2025) to 21.93%, marking a decrease of 9.58%.
• For Net Profit, as of Jun 2025, the value is 8.19 Cr.. The value appears strong and on an upward trend. It has increased from -2.88 Cr. (Mar 2025) to 8.19 Cr., marking an increase of 11.07 Cr..
• For EPS in Rs, as of Jun 2025, the value is 7.47. The value appears strong and on an upward trend. It has increased from -2.54 (Mar 2025) to 7.47, marking an increase of 10.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 5:15 am

Growth

Last Updated: September 5, 2025, 1:31 pm

Balance Sheet

Last Updated: May 13, 2025, 2:43 pm

Below is a detailed analysis of the balance sheet data for SIL Investments Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
• For Reserves, as of Mar 2025, the value is 3,135.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,187.00 Cr. (Mar 2024) to 3,135.00 Cr., marking an increase of 948.00 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 393.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 226.00 Cr. (Mar 2024) to 393.00 Cr., marking an increase of 167.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,539.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,423.00 Cr. (Mar 2024) to 3,539.00 Cr., marking an increase of 1,116.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 110.00 Cr.. The value appears to be declining and may need further review. It has decreased from 112.00 Cr. (Mar 2024) to 110.00 Cr., marking a decrease of 2.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 3,345.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,245.00 Cr. (Mar 2024) to 3,345.00 Cr., marking an increase of 1,100.00 Cr..
• For Other Assets, as of Mar 2025, the value is 83.00 Cr.. The value appears strong and on an upward trend. It has increased from 65.00 Cr. (Mar 2024) to 83.00 Cr., marking an increase of 18.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,539.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,423.00 Cr. (Mar 2024) to 3,539.00 Cr., marking an increase of 1,116.00 Cr..

Notably, the Reserves (3,135.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for SIL Investments Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 29.19. This value is within the healthy range. It has increased from 27.76 (Mar 24) to 29.19, marking an increase of 1.43.
• For Diluted EPS (Rs.), as of Mar 25, the value is 29.19. This value is within the healthy range. It has increased from 27.76 (Mar 24) to 29.19, marking an increase of 1.43.
• For Cash EPS (Rs.), as of Mar 25, the value is 31.89. This value is within the healthy range. It has increased from 29.91 (Mar 24) to 31.89, marking an increase of 1.98.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,964.52. It has increased from 2,124.46 (Mar 24) to 2,964.52, marking an increase of 840.06.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,964.52. It has increased from 2,124.46 (Mar 24) to 2,964.52, marking an increase of 840.06.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 51.67. It has increased from 48.05 (Mar 24) to 51.67, marking an increase of 3.62.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 41.89. This value is within the healthy range. It has increased from 41.05 (Mar 24) to 41.89, marking an increase of 0.84.
• For PBIT / Share (Rs.), as of Mar 25, the value is 39.48. This value is within the healthy range. It has increased from 39.44 (Mar 24) to 39.48, marking an increase of 0.04.
• For PBT / Share (Rs.), as of Mar 25, the value is 39.47. This value is within the healthy range. It has increased from 39.03 (Mar 24) to 39.47, marking an increase of 0.44.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 29.48. This value is within the healthy range. It has increased from 28.30 (Mar 24) to 29.48, marking an increase of 1.18.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 29.14. This value is within the healthy range. It has increased from 27.73 (Mar 24) to 29.14, marking an increase of 1.41.
• For PBDIT Margin (%), as of Mar 25, the value is 81.08. This value is within the healthy range. It has decreased from 85.44 (Mar 24) to 81.08, marking a decrease of 4.36.
• For PBIT Margin (%), as of Mar 25, the value is 76.41. This value exceeds the healthy maximum of 20. It has decreased from 82.08 (Mar 24) to 76.41, marking a decrease of 5.67.
• For PBT Margin (%), as of Mar 25, the value is 76.39. This value is within the healthy range. It has decreased from 81.22 (Mar 24) to 76.39, marking a decrease of 4.83.
• For Net Profit Margin (%), as of Mar 25, the value is 57.05. This value exceeds the healthy maximum of 10. It has decreased from 58.90 (Mar 24) to 57.05, marking a decrease of 1.85.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 56.40. This value exceeds the healthy maximum of 20. It has decreased from 57.72 (Mar 24) to 56.40, marking a decrease of 1.32.
• For Return on Networth / Equity (%), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 15. It has decreased from 1.33 (Mar 24) to 0.98, marking a decrease of 0.35.
• For Return on Capital Employeed (%), as of Mar 25, the value is 1.18. This value is below the healthy minimum of 10. It has decreased from 1.72 (Mar 24) to 1.18, marking a decrease of 0.54.
• For Return On Assets (%), as of Mar 25, the value is 0.87. This value is below the healthy minimum of 5. It has decreased from 1.21 (Mar 24) to 0.87, marking a decrease of 0.34.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.01. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 3,895.57. This value exceeds the healthy maximum of 3. It has increased from 1,543.15 (Mar 24) to 3,895.57, marking an increase of 2,352.42.
• For Quick Ratio (X), as of Mar 25, the value is 3,895.57. This value exceeds the healthy maximum of 2. It has increased from 1,543.15 (Mar 24) to 3,895.57, marking an increase of 2,352.42.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 9.00 (Mar 24) to 0.00, marking a decrease of 9.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 8.51 (Mar 24) to 0.00, marking a decrease of 8.51.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 91.00 (Mar 24) to 0.00, marking a decrease of 91.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 91.49 (Mar 24) to 0.00, marking a decrease of 91.49.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4,445.00. This value is within the healthy range. It has increased from 99.59 (Mar 24) to 4,445.00, marking an increase of 4,345.41.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3,129.00. This value is within the healthy range. It has increased from 69.66 (Mar 24) to 3,129.00, marking an increase of 3,059.34.
• For Enterprise Value (Cr.), as of Mar 25, the value is 599.37. It has increased from 487.23 (Mar 24) to 599.37, marking an increase of 112.14.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 10.93. This value exceeds the healthy maximum of 3. It has increased from 9.56 (Mar 24) to 10.93, marking an increase of 1.37.
• For EV / EBITDA (X), as of Mar 25, the value is 13.48. This value is within the healthy range. It has increased from 11.19 (Mar 24) to 13.48, marking an increase of 2.29.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 11.11. This value exceeds the healthy maximum of 3. It has increased from 9.70 (Mar 24) to 11.11, marking an increase of 1.41.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 90.99 (Mar 24) to 0.00, marking a decrease of 90.99.
• For Price / BV (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 1. It has decreased from 0.22 (Mar 24) to 0.19, marking a decrease of 0.03.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 11.11. This value exceeds the healthy maximum of 3. It has increased from 9.70 (Mar 24) to 11.11, marking an increase of 1.41.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness